Misagh Karimi

1.3k total citations
7 papers, 35 citations indexed

About

Misagh Karimi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Misagh Karimi has authored 7 papers receiving a total of 35 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Misagh Karimi's work include Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Misagh Karimi is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Misagh Karimi collaborates with scholars based in United States. Misagh Karimi's co-authors include Daniel Schmolze, Heloisa P. Soares, Paul Frankel, Daniel Lin, Cary A. Presant, Linda D. Bosserman, C. Willis, James Rutledge, Yujie Cui and Weihua Guo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Oncologist.

In The Last Decade

Misagh Karimi

6 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misagh Karimi United States 4 21 10 8 6 6 7 35
Beatriz Rojas Spain 3 18 0.9× 11 1.1× 5 0.6× 3 0.5× 5 0.8× 7 30
Nuntana Dinglasan United States 2 19 0.9× 8 0.8× 19 2.4× 5 0.8× 4 0.7× 5 35
Jennifer M. Koziak Canada 3 14 0.7× 12 1.2× 6 0.8× 10 1.7× 5 0.8× 3 45
Lucía González Cortijo Spain 5 19 0.9× 10 1.0× 13 1.6× 3 0.5× 3 0.5× 11 51
Abraham Tzou United States 1 13 0.6× 10 1.0× 5 0.6× 4 0.7× 6 1.0× 2 26
Brandon Nadres United States 3 29 1.4× 9 0.9× 15 1.9× 9 1.5× 7 1.2× 4 33
M Bader Germany 3 22 1.0× 11 1.1× 8 1.0× 3 0.5× 4 0.7× 4 32
Jin Suminokura Japan 5 22 1.0× 6 0.6× 13 1.6× 3 0.5× 7 1.2× 9 46
Madison Crutcher United States 6 31 1.5× 10 1.0× 16 2.0× 7 1.2× 12 2.0× 14 58
Pier Ramos-Elías Mexico 4 25 1.2× 13 1.3× 6 0.8× 3 0.5× 2 0.3× 9 38

Countries citing papers authored by Misagh Karimi

Since Specialization
Citations

This map shows the geographic impact of Misagh Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misagh Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misagh Karimi more than expected).

Fields of papers citing papers by Misagh Karimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misagh Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misagh Karimi. The network helps show where Misagh Karimi may publish in the future.

Co-authorship network of co-authors of Misagh Karimi

This figure shows the co-authorship network connecting the top 25 collaborators of Misagh Karimi. A scholar is included among the top collaborators of Misagh Karimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misagh Karimi. Misagh Karimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Egelston, Colt A., Weihua Guo, Susan E. Yost, et al.. (2023). Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunology Immunotherapy. 72(9). 3013–3027. 14 indexed citations
3.
Yuan, Yuan, Susan E. Yost, Jin Sun Lee, et al.. (2022). Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.. Journal of Clinical Oncology. 40(16_suppl). e13071–e13071. 1 indexed citations
4.
Meza, Luís, Aleksandr Filippov, Nazlı Dizman, et al.. (2021). Radiomic features of renal cell carcinoma primary and metastatic sites as predictors of TERT and BAP1 mutations.. Journal of Clinical Oncology. 39(6_suppl). 282–282. 1 indexed citations
5.
Loaiza‐Bonilla, Arturo, Al B. Benson, Axel Grothey, et al.. (2021). Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group. The Oncologist. 26(8). 651–659. 5 indexed citations
6.
Karimi, Misagh, et al.. (2020). Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model. Journal of Clinical Medicine. 9(6). 1687–1687. 4 indexed citations
7.
Bosserman, Linda D., C. Willis, Pat W. Whitworth, et al.. (2015). Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer. PLoS ONE. 10(5). e0122609–e0122609. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026